Amplify Weight Loss Drug & Treatment ETF (THNR) Institutional Ownership $18.85 -0.32 (-1.67%) Closing price 04:10 PM EasternExtended Trading$18.85 0.00 (-0.02%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Institutional Ownership Changes (13F Filings) for Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$730.60KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$238.70K Get THNR Insider Trade Alerts Want to know when executives and insiders are buying or selling Amplify Weight Loss Drug & Treatment ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data THNR Institutional Buying and Selling by Quarter Remove Ads Amplify Weight Loss Drug & Treatment ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025GTS Securities LLC24,867$561K0.0%+95.2%0.000% 2/14/2025Jane Street Group LLC23,676$534K0.0%+62.7%0.000% 2/10/2025Harbour Investments Inc.6,888$155K0.0%-28.0%0.000% 11/15/2024Jane Street Group LLC14,553$390K0.0%-31.4%0.000% 11/5/2024Harbour Investments Inc.9,563$256K0.0%+43.4%0.000% 7/26/2024Harbour Investments Inc.6,668$174K0.0%N/A0.000% (Data available from 1/1/2016 forward)Remove Ads THNR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of THNR shares? During the previous two years, the following institutional investors and hedge funds held shares of Amplify Weight Loss Drug & Treatment ETF shares: GTS Securities LLC ($561K), and Jane Street Group LLC ($534K), Harbour Investments Inc. ($155K).Learn more on THNR's institutional investors. Which institutional investors have been buying Amplify Weight Loss Drug & Treatment ETF stock? The following institutional investors have purchased Amplify Weight Loss Drug & Treatment ETF stock in the last 24 months: GTS Securities LLC ($12.13K), Harbour Investments Inc. ($9.56K), and Jane Street Group LLC ($9.12K). How much institutional buying is happening at Amplify Weight Loss Drug & Treatment ETF? Institutional investors have bought a total of 30,813 shares in the last 24 months. This purchase volume represents approximately $730.60K in transactions. Which Amplify Weight Loss Drug & Treatment ETF major shareholders have been selling company stock? The following institutional investors have sold Amplify Weight Loss Drug & Treatment ETF stock in the last 24 months: Jane Street Group LLC ($6.66K), and Harbour Investments Inc. ($2.68K). How much institutional selling is happening at Amplify Weight Loss Drug & Treatment ETF? Institutional investors have sold a total of 9,331 shares in the last 24 months. This volume of shares sold represents approximately $238.70K in transactions. Related Companies First Trust Indxx Metaverse ETF Institutional Ownership iShares Neuroscience and Healthcare ETF Institutional Ownership ProShares Decline of the Retail Store ETF Institutional Ownership AGF Global Infrastructure ETF Institutional Ownership SPDR MSCI USA Climate Paris Aligned ETF Institutional Ownership Xtrackers US Green Infrastructure Select Equity ETF Institutional Ownership Direxion Daily Travel & Vacation Bull 2X Shares Institutional Ownership Harbor Corporate Culture Leaders ETF Institutional Ownership AdvisorShares Restaurant ETF Institutional Ownership KraneShares MSCI One Belt One Road ETF Institutional Ownership This page (NYSEARCA:THNR) was last updated on 4/8/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredDividend cuts are destroying retirements… is yours next?The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredFBI Warns: Wave Of Retiree Cyber Hacks Coming In 2025Try to think back to the fall of 2008… The pandemic accelerated America's descent into a “no-cash society” ...Colonial Metals | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWill the U.S. military protect this $10B gold mine?You don’t need the gold price to move another inch for this company to potentially re-rate several hundred per...Golden Portfolio | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
